NR
Nirmala Rajesh Wankhede
About Nirmala Rajesh Wankhede
Data last updated:
Nirmala Rajesh Wankhede is a Director at Medspark Pharmaventures Private Limited (since 2019). The company operates in Chemicals. Medspark Pharmaventures Private Limited reported revenue of ₹10.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medspark Pharmaventures Private Limited U24100MH2019PTC321600 | Director | 21 Feb 2019 | 2019 | ₹10.3 Lakh (FY 2023) | Active |
Board colleagues of Nirmala Rajesh Wankhede
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Zoting | 03147716 | Medspark Pharmaventures Private Limited | Director |
| Rajesh Vitthalrao Mandawkar | 07086244 | Medspark Pharmaventures Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmala Rajesh Wankhede
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmala Rajesh Wankhede
Nirmala Rajesh Wankhede currently holds 1 directorship: Medspark Pharmaventures Private Limited (Director, since 21 Feb 2019, revenue ₹10.3 Lakh (FY 2023)).
Nirmala Rajesh Wankhede was first appointed on 21 Feb 2019 as Director at Medspark Pharmaventures Private Limited.
The current boards of Nirmala Rajesh Wankhede's companies include Amit Zoting (Medspark Pharmaventures Private Limited), Rajesh Vitthalrao Mandawkar (Medspark Pharmaventures Private Limited).